Search Results 1351-1360 of 17906 for monoclonal antibody

1. A Study of ANV419 Alone or in Combination With Approved Treatment in Patients With Cutaneous Melanoma (OMNIA-1) - Mayo Clinic

   ... antibody or with anti-CTLA4 antibody in adult participants with advanced (unresectable or metastatic) cutaneous melanoma. Participation eligibility.

2. Genetic Analysis in Blood and Tumor Samples From Patients With Advanced or Metastatic Estrogen Receptor Positive and HER2 Negative Breast Cancer Receiving Palbociclib and Endocrine Therapy - Mayo Clinic

   Monoclonal antibodies ≤ 2 weeks;; Note: denosumab is exempt from this requirement and can be started at any time prior to initiation of palbociclib and ...

3. An International Prospective Open-label, Randomized, Phase III Study Comparing 177Lu-PSMA-617 in Combination With Soc, Versus SoC Alone, in Adult Male Patients With mHSPC - Mayo Clinic

   (including monoclonal antibodies). 3. Concurrent cytotoxicity chemotherapy, immunotherapy, radioligand therapy, PARP inhibitor, biological therapy or ...

4. Medical Research & Education - Mayo Clinic News Network

   Is the definition of Alzheimer's disease changing? Dana Sparks. November 6, 2018. Mayo researchers correlate specific antibody with relapse of neurological ...

5. A Study Of ABBV-383 With Relapsed Refractory Waldenström Macroglobulinemia - Mayo Clinic

   Subject is naïve to treatment with ABBV-383 or anti-BCMA bispecific antibodies. ... Received a monoclonal antibody given with anti-neoplastic intent ≤30 days ...

6. Assessment Of LBR-101 In Chronic Migraine - Mayo Clinic

   Treatment with an investigational drug or device within 30 days of study entry or any prior exposure to a monoclonal antibody targeting the CGRP pathway.

7. Myoclonus - Symptoms and causes - Mayo Clinic

   Myoclonus refers to a quick jerking movement that you can't control. Hiccups are a form of myoclonus, as are the sudden jerks or "sleep starts" that you may ...

8. Polymer Shielding of Vectors and Vaccines - Virology, Vector and Vaccine Engineering: Michael A. Barry - Mayo Clinic Research

   PEGylation also reduces the production of new antibody and cellular immune responses against Ad. The Virology, Vector and Vaccine Engineering Lab has ...

9. A Study to Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants With Immunoglobulin Light Chain (AL) Amyloidosis Receiving ABBV-383 as an Intravenous (IV) Infusion - Mayo Clinic

   (dFLC) >= 50 mg/L. - Has previously been exposed to a proteasome inhibitor (PI) and an anti-CD38 monoclonal antibody. Exclusion Criteria: - Known history of ...

10. A Study of PY314 in Subjects With Advanced Solid Tumors - Mayo Clinic

    monoclonal antibody therapy (except for bone-modifying agents as supportive care), radiotherapy, or any other agents to treat cancer within 21 days ...